TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

pablo villalba

T3 · host / generalist

Engineer and entrepreneur building a clinical-stage hair regrowth company using NASA-derived electromagnetic stimulation technology. Previously connected with SeedRocket while surfing in Porto. Leads a team including his sister (engineer), a former FDA reviewer, dermatologists, and a China supply-chain expert. Pursuing FDA device clearance with a strategic partnership from Turkey's largest Dysport/Botox distributor.

1 call·1 name·100% bull·last heard 9 months ago·SeedRocket TV
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$VILLALBA-CAPILARVillalba Capilarposition

Founder pitches electromagnetic hair regrowth cap pursuing FDA clearance with Turkish strategic backing

Electromagnetic stimulation at 100Hz reactivates viable but thinning hair follicles using NASA-derived bone regeneration technology; pursuing FDA device pathway (faster than drugs) with clinical data from 72-patient study funded by Turkey's largest Dysport distributor.

SeedRocket TV2026-01episode →

most discussed · click a bar to filter

  • $VILLALBA-CAPILAR

recurring themes

  • Healthcare Systems & Policy2
  • Medical Aesthetics Devices1
  • SaaS Business Models1
  • Longevity & Aging1
1 total
$VILLALBA-CAPILAR
Villalba Capilar
HIGHpablo villalba·SeedRocket TV·9 months ago·A CAP against BALDNESS? | Pablo Villalba's new project· position
Founder pitches electromagnetic hair regrowth cap pursuing FDA clearance with Turkish strategic backing
Electromagnetic stimulation at 100Hz reactivates viable but thinning hair follicles using NASA-derived bone regeneration technology; pursuing FDA device pathway (faster than drugs) with clinical data from 72-patient study funded by Turkey's largest Dysport distributor.
"Eso es es hacemos investigación médica y estética y nos hemos metido en dos tecnologías eh de regeneración capital capilar y este es el primer producto que... Es una gorra. Es par…"
0:11
8
Healthcare Systems & Policytailwind
Medical device FDA pathway offers years-faster approval vs drugs, attracting strategic aesthetic partners
Classifying hair regrowth as a medical device rather than drug cuts regulatory timeline from 10+ years to months, enabling faster commercialization and attracting established aesthetic distributors (e.g., Turkey's top Dysport seller) to fund clinical trials.
7
Medical Aesthetics Devicestailwind
Electromagnetic stimulation cap targets hair loss via NASA bone-healing tech with FDA device pathway
Low-frequency electromagnetic fields (100Hz) can reactivate viable hair follicles by leveraging cellular magnetic sensitivity, offering a non-pharmacological alternative to minoxidil/finasteride with fewer side effects; the FDA device pathway provides faster regulatory clearance than drugs.
7
SaaS Business Modelstailwind
Zero-payback consumer subscription model powered by onboarding and Pinterest distribution
8Fit achieved zero-day payback on marketing spend through intensive onboarding questionnaires that created user investment, combined with Pinterest as primary acquisition channel targeting moms, enabling tripling revenue yearly to $24M ARR.
6
Longevity & Agingtailwind
Hair loss treatment shifts from taboo to wellness category, mirroring GLP-1/obesity trajectory
Hair loss is following the same destigmatization path as weight loss, moving from hidden shame to open wellness category; early clinical validation and physician endorsement (dermatologists) are key to unlocking mass-market adoption.
6
Healthcare Systems & Policytailwind
Hiring FDA reviewer as key regulatory strategy for medical device clearance
Steamfield recruited an FDA reviewer (expert in needles/lasers) to navigate the 510(k) clearance pathway, demonstrating a playbook for medtech startups to de-risk regulatory timelines by embedding regulatory expertise.